MANTOVANI, LORENZO
MANTOVANI, LORENZO
DIPARTIMENTO DI SCIENZE FARMACOLOGICHE (attivo dal 01/01/2001 al 27/04/2012)
A 10-year, randomized, clinical trial on prophylaxis vs. on-demand treatment in children with haemophilia A : the E.S.P.R.I.T. study
2008-07-01 A. Gringeri, B. Lundin, S. von Mackensen, L. Mantovani, P.M. Mannucci
A randomized clinical trial of prophylaxis in children with hemophilia A (the ESPRIT Study)
2011-04-01 A. Gringeri, B. Lundin, S. von Mackensen, L. Mantovani, P.M. Mannucci, E. Study Group
A randomized clinical trial on prophylaxis vs. episodic treatment in children with haemophilia A : the ESPRIT study
2010-07-01 A. Gringeri, B. Lundin, S. Von Mackensen, L. Mantovani, P.M. Mannucci
Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors
2011-11-03 C. Leissinger, A. Gringeri, B. Antmen, E. Berntorp, C. Biasoli, S. Carpenter, P. Cortesi, H. Jo, K. Kavakli, R. Lassila, M. Morfini, C. Négrier, A. Rocino, W. Schramm, M. Serban, M.V. Uscatescu, J. Windyga, B. Zülfikar, L. Mantovani
Cost of care and quality of life for patients with hemophilia complicated by inhibitors : the COCIS Study Group
2003-10-01 A. Gringeri, L. Mantovani, L. Scalone, P. M. Mannucci, COCIS Study Group
Cost, quality of life, treatment satisfaction and compliance in patients with β-thalassemia major undergoing iron chelation therapy : the ITHACA study
2008-07-01 L. Scalone, L. Mantovani, M. Krol, D. Rofail, S. Ravera, M.G. Bisconte, C. Borgna-Pignatti, Z. Borsellino, P. Cianciulli, D. Gallisai, L. Prossomariti, S. Ippazio, M.D. Cappellini
Differences between patients', physicians' and pharmacists' preferences for treatment products in haemophilia : a discrete choice experiment
2005-01-01 G. Tagariello, R. Musso, G. Piseddu, A. Rocino, G. Rodorigo, G. Rossetti, F.A. Scaraggi, P. Schinco, A. Tagliaferri, R. Targhetta, M. Morfini, V.T. Lombardo, E. Zanon, M. Schiavoni, L. Bizzoni, A. Iorio, P. Iannaccaro, E. Santagostino, M. D'Inca, D. Bertuzzo, G. Feola, A. Coppola, L. Contino, G. Castaman, G. Mancuso, E. Boeri, A. Dragani, A. Billio, F. Baudo, G. Barillari, A. Gringeri, M. Villa, L. Scalone, P.M. Mannucci, M.S. Monzini, L.G. Mantovani, B. Caputo, G. Delios
Haemophilia prophylaxis : how can we justify the costs?
2012-09-01 B.M. Feldman, K. Berger, R. Bohn, M. Carcao, K. Fischer, A. Gringeri, K. Hoots, L. Mantovani, A.R. Willian, W. Schramm
Health related quality of life in scleroderma patients treated with two different intravenous iloprost regimens
2018-01-01 T. Schioppo, L. Scalone, P. Cozzolino, L. Mantovani, G. Cesana, O. DE LUCIA, A. Murgo, F. Ingegnoli
The importance of baseline viral load when assessing relative efficacy in treatment-naïve HBeAg-positive chronic hepatitis B : a systematic review and network meta-analysis
2014-01-01 S. Mealing, I. Ghement, N. Hawkins, D.A. Scott, B. Lescrauwaet, M. Watt, M. Thursz, P. Lampertico, L. Mantovani, E. Morais, B. Bregman, M. Cucherat
Optimising the clinical strategy for autoimmune liver diseases : Principles of value-based medicine
2018-04-01 M. Carbone, L. Cristoferi, P.A. Cortesi, M. Rota, A. Ciaccio, S. Okolicsanyi, M. Gemma, L. Scalone, G. Cesana, L. Fabris, M. Colledan, S. Fagiuoli, G. Ideo, L.S. Belli, L.M. Munari, L. Mantovani, M. Strazzabosco
Patients', physicians', and pharmacists' preferences towards coagulation factor concentrates to treat haemophilia with inhibitors : results from the COHIBA Study
2009-03-01 L. Scalone, L. Mantovani, F. Borghetti, S. Von Mackensen, A. Gringeri
Pharmacoeconomic consequences of amlodipine besylate therapy in patients undergoing PTCA
2006-01-01 Francesca Rossetti, Simona De Portu, Enrica Menditto, Luciana Scalone, Silvia Bustacchini, Claudio Cricelli, Lorenzo Giovanni Mantovani
The pharmacoeconomic impact of amlodipine use on coronary artery disease
2006-01-01 Simona De Portu, Enrica Menditto, Luciana Scalone, Silvia Bustacchini, Claudio Cricelli, Lorenzo Giovanni Mantovani
Preferences towards the characteristics of coagulation factor concentrates used to treat hemophilic patients with inhibitors : the patients', physicians' and pharmacists' perspective
2008-07-01 A. Gringeri, F. Borghetti, L. Scalone, S. von Mackensen, L. Mantovani
Primary and secondary prophylaxis in children with haemophilia A reduces bleeding frequency and arthropathy development compared to on-demand treatment : a 10-year, randomized, clinical trial
2009-07-01 A. Gringeri, B. Lundin, S. Von Mackensen, L. Mantovani, P.M. Mannucci
Prospective cost-effectiveness study of regular continuous prophylactic replacement therapy in adults with severe hemophilia A
2008-07-01 A. Gringeri, M.S. Monzini, S. von Mackensen, M. Muça-Perja, F. Borghetti, L. Mantovani
Quality of life in hemophilic patients without inhibitors : the COCHE study
2005-01-01 L. Scalone, A. Gringeri, S. Von Mackensen, P.M. Mannucci, S. De Silvo, M. Anastasia, F. DI STASI, L.G. Mantovani
Quality of life is associated to the orthopaedic status in haemophilic patients with inhibitors
2006-01-01 L. SCALONE, L. G. MANTOVANI, P. M. MANNUCCI, A. GRINGERI, THE COCIS STUDY INVESTIGATORS
Resource consumption in haemophilia care – the ESCHQoL study (European study of clinical, health economic and quality of life outcomes in haemophilia treatment)
2009-07-01 K. Berger, M. Bullinger, P. Giangrande, A. Giebl, A. Gringeri, R. Ljung, L. Nemes, S. Von Mackensen, L. Mantovani, M. Serban, M. Shlaen, W. Schramm